Compare ELVN & FWRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ELVN | FWRG |
|---|---|---|
| Founded | 2016 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 975.9M |
| IPO Year | 2020 | 2021 |
| Metric | ELVN | FWRG |
|---|---|---|
| Price | $29.21 | $12.19 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 12 |
| Target Price | ★ $41.00 | $20.64 |
| AVG Volume (30 Days) | 752.0K | ★ 2.0M |
| Earning Date | 03-03-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 3.17 | ★ 3.33 |
| EPS | N/A | ★ 0.31 |
| Revenue | N/A | ★ $1,222,501,000.00 |
| Revenue This Year | N/A | $15.58 |
| Revenue Next Year | N/A | $12.67 |
| P/E Ratio | ★ N/A | $40.00 |
| Revenue Growth | N/A | ★ 20.34 |
| 52 Week Low | $13.30 | $11.44 |
| 52 Week High | $31.76 | $19.84 |
| Indicator | ELVN | FWRG |
|---|---|---|
| Relative Strength Index (RSI) | 52.42 | 38.68 |
| Support Level | $19.10 | $11.44 |
| Resistance Level | $29.63 | $13.16 |
| Average True Range (ATR) | 1.87 | 0.59 |
| MACD | -0.23 | 0.10 |
| Stochastic Oscillator | 39.76 | 40.70 |
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
First Watch Restaurant Group Inc is a daytime restaurant concept serving made-to-order breakfast, brunch, and lunch using fresh ingredients. It generates revenues from Restaurant sales and Franchise revenues.